Scientists have reported results from an early-stage trial of an immunotherapy drug called VIR-5500. The drug offers new hope for men with advanced prostate cancer who have stopped responding to other ...

A targeted cancer drug niraparib, used in combination with hormone therapy, was found to reduce the risk of prostate tumor growth and slow symptom advance. File Photo by Billie Jean Shaw/UPI A new ...

The new drug, known as VIR-5500, uses a so-called cloaking device and only activates when it reaches the tumour ...

Therapeutic Dr Allen’s Devices are designed to treat different chronic health conditions, including kidney stones (known as nephrolithiasis), prostate enlargement (commonly known as BPH), chronic ...

Prostate cancer that has become resistant to hormone therapy could be treated using a new drug that is currently in clinical trials for ovarian and bile duct cancer, according to research published in ...

Relief for men experiencing the challenges of Benign Prostatic Hyperplasia (BPH), or prostate enlargement, has arrived with the introduction of Flowel and Flowel Plus by Superior Pharmaceuticals ...

A drug for advanced prostate cancer has shown “remarkable” results in an early-stage trial, with patients who had previously stopped being receptive to treatment finding their tumours shrinking, ...